Cabergoline for Rats: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Cabergoline is a dopamine agonist medication that lowers prolactin release from the pituitary gland. In pet rats, your vet may use it extra-label, which means it is prescribed based on veterinary judgment rather than a rat-specific FDA approval. That is common in exotic pet medicine.

In rats, cabergoline is most often discussed when a vet suspects a pituitary tumor or a prolactin-driven problem, especially in older females with mammary masses. It does not remove a tumor, and it is not the right choice for every rat. Instead, it may help reduce hormone-driven effects and improve comfort or function in selected cases.

Because rats are small and doses are tiny, cabergoline is often given as a compounded liquid or carefully divided tablet. Accurate measuring matters. A very small dosing error can become a big one in a rat, so pet parents should only use the exact product and instructions provided by their vet.

In rats, cabergoline is used most often as part of care for pituitary adenoma or pituitary tumor cases, especially when neurologic signs suggest the pituitary gland may be involved. Your vet may also consider it for some rats with mammary tumor development linked to prolactin-secreting pituitary disease. Published exotic-animal references describe palliative use in these situations rather than a cure.

Common reasons a rat may be prescribed cabergoline include weakness in the front legs, trouble holding food, balance changes, reduced grooming, behavior changes, or a mammary mass that seems to be influenced by hormone activity. In some rats, the goal is to improve day-to-day quality of life. In others, the goal is to slow progression of clinical signs for a period of time.

Cabergoline is usually only one part of the plan. Your vet may pair it with supportive feeding, pain control, anti-inflammatory medication, nursing care, or surgery for a separate mammary mass when appropriate. The best plan depends on your rat's age, symptoms, tumor location, and overall comfort.

Cabergoline dosing for rats should be set by your vet. A commonly cited exotic-animal dose for a rat with pituitary adenoma is 0.6 mg/kg by mouth every 72 hours. That said, real-world dosing can vary based on the diagnosis, the formulation your pharmacy prepares, how your rat responds, and whether other medications are being used.

Because cabergoline is potent, pet parents should never estimate a dose from a human tablet without veterinary instructions. Many rats receive a compounded oral suspension so the dose can be measured more accurately. If your vet prescribes tablets, ask exactly how to split or prepare them. Do not switch brands, strengths, or compounded concentrations unless your vet confirms the new volume.

Cabergoline may be given with a small amount of food if your vet approves, which can help if nausea occurs. If your rat spits out part of the dose, drools, or you are not sure how much was swallowed, contact your vet before redosing. Double-dosing can be risky.

Rechecks matter. Your vet may adjust the schedule based on whether your rat is eating better, moving better, or showing new side effects. If the medication does not seem to help, that does not always mean anyone did something wrong. It may mean the underlying disease is progressing or that another diagnosis is more likely.

Cabergoline is often tolerated reasonably well, but side effects can happen. The most commonly discussed problems with dopamine-agonist drugs are decreased appetite, nausea, vomiting, lethargy, weakness, and digestive upset. In rats, pet parents may notice these as less interest in treats, slower movement, hiding, or weight loss.

Some rats may seem sleepy after a dose. Others may act off-balance or weaker, which can be hard to separate from the disease being treated. That is why careful observation is so important. If your rat suddenly stops eating, cannot reach food, becomes severely weak, or seems distressed, see your vet immediately.

Call your vet promptly if you notice repeated refusal of food, marked weight loss, worsening neurologic signs, diarrhea, persistent drooling after dosing, or any dramatic change in behavior. Your vet may adjust the dose, change the formulation, add supportive care, or decide that a different treatment path makes more sense.

Cabergoline works through dopamine pathways, so it can interact with medications that block dopamine or strongly affect the nervous system. Drugs such as metoclopramide and some antipsychotic-type medications may reduce cabergoline's intended effect because they oppose dopamine activity.

Your vet will also want to know about any other medicines, supplements, or compounded products your rat receives. Sedatives, pain medications, and anti-nausea drugs are not always incompatible, but the full medication list helps your vet judge whether side effects like sedation, poor appetite, or low activity are coming from one drug or from the combination.

Do not start, stop, or combine medications on your own. That includes leftover medications from another pet. If your rat is being treated for a pituitary tumor, mammary mass, or another chronic condition, ask your vet to review the whole plan together so each medication has a clear purpose.